Business

US patent allowed for NNZ-2591 to treat Pitt Hopkins

US patent allowed for NNZ-2591 to treat Pitt Hopkins

articleNeuren Pharmaceuticals LimitedJune 25, 20254/company/neuren-pharmaceuticals-ltd/news/us-patent-allowed-for-nnz-2591-to-treat-pitt-hopkins
US patent allowed for NNZ-2591 to treat Pitt Hopkins

About this update from Neuren Pharmaceuticals Limited

[{"type":"text","content":"Neuren Pharmaceuticals Ltd has released a press release. View Attachment","length":249,"tagName":"div"}]

More updates from Neuren Pharmaceuticals Limited